UNITED
STATES

SECURITIES
AND EXCHANGE COMMISSION



WASHINGTON,
D.C. 20549



FORM
10-Q



☑
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGE ACT OF 1934



For
the quarterly period ended March 31, 2012



☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934



For
the transition period from		to



Commission
file number	0-31927



LASERLOCK
TECHNOLOGIES, INC.

(Exact
Name of Registrant as Specified in Its Charter)





| | Nevada                                                             |                                                          | 23-3023677                           | 
| | ------------------------------------------------------------------ | -------------------------------------------------------- | ------------------------------------ | 
| | (State or Other Jurisdiction of Incorporation
    or Organization) |                                                          | (I.R.S. Employer Identification No.) | 
| |                                                                    |                                                          |                                      | 
| |                                                                    |                                                          |                                      | 
| | 837 Lindy Lane Bala Cynwyd, PA                                     |                                                          | 19004                                | 
| | (Address of Principal Executive Offices
    )                      |                                                          | (Zip Code)                           | 
| |                                                                    | (610)
    668-1952                                       |                                      | 
| |                                                                    | (Registrant’s Telephone Number,
    Including Area Code) |                                      | 
| |                                                                    |                                                          |                                      | 
| |                                                                    |                                                          |                                      | 





(Former
Name, Former Address and Former Fiscal year, if Changed Since Last Report)



Indicate
by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90 days). Yes ☐ No ☑



Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulations S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes☐ No ☑



Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller
reporting company" in Rule 12b-2 of the Exchange Act.

|                            |   |                           |  
|--------------------------- | - | ------------------------- | -
|Large
    accelerated filer | ☐ | Accelerated filer         | ☐
|Non-accelerated filer       | ☐ | Smaller reporting company | ☑
|                            |   |                           |  



(Do
not check if a smaller reporting company)



Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes ☐No ☑



Indicate
the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 145,144,603
shares of common stock outstanding at August 24, 2012.













Form
10-Q

June
30, 2012

TABLE OF CONTENTS



|           |                                                                                          | Page
|---------- | ---------------------------------------------------------------------------------------- | ----
|           | PART I                                                                                   |     
|Item 1.    | Financial Statements                                                                    
|           | Condensed
    Consolidated Balance Sheets                                                | 3   
|           | Condensed Consolidated Statements of
                                    Operations      | 4   
|           | Condensed
                                    Consolidated Statements of Cash Flows      | 6   
|           | Condensed Consolidated Statement of Stockholders equity (
    deficit     )              | 5   
|           | Condensed
    Consolidated Notes to the Financials Statements                            | 7   
|Item 2.    | Management’s Discussion and
    Analysis of Financial Condition and Results of Operation | 16  
|Item 3.    | Quantitative and Qualitative Disclosures
    About Market Risk                           |     
|Item 4T    | Controls and Procedures                                                                  | 20  
|           |                                                                                          |     
|           | PART II                                                                                  |     
|Item 6.    | Exhibits                                                                                 | 21  
|           |                                                                                         
|SIGNATURES | 22                                                                                      









PART
I - FINANCIAL INFORMATION



ITEM
1.	FINANCIAL STATEMENTS



LaserLock
Technologies, Inc. and Subsidiary

(A
Development Stage Company)





CONTENTS





|CONDENSED CONSOLIDATED BALANCE
    SHEETS (Unaudited)                     
|--------------------------------------------------------------------------
|                                                                          
|                                                                          
|CONDENSED CONSOLIDATED STATEMENTS
    OF OPERATIONS (Unaudited)           
|                                                                          
|                                                                          
|CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS'
    DEFICIT (Unaudited)
|                                                                          
|                                                                          
|CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)               
|                                                                          
|                                                                          
|NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
    (Unaudited)      











LaserLock
Technologies, Inc. and Subsidiary

(A
Development Stage Company)

Condensed
Consolidated Balance Sheets

March
31, 2012 and December 31, 2011





|                                                                 |  | March 31, 2012 |             | December 31,2011
|---------------------------------------------------------------- |  | -------------- | ----------- | ----------------
|                                                                 |  | (Unaudited)    |             |                 
|ASSETS                                                           |  |                |             |                 
|                                                                 |  |                |             |                 
|CURRENT ASSETS                                                   |  |                |             |                 
|Cash and cash equivalents                                        |  | $              | 19,793      |                 
|Accounts receivable, net of allowance of $0 at                   |  |                |             |                 
|March 31, 2012 and December 31, 2011                             |  |                | 3,060       |                 
|Inventory                                                        |  |                | 33,101      |                 
|Deferred finance charges                                         |  |                | 9,313       |                 
|Prepaid expenses                                                 |  |                | 87,382      |                 
|                                                                 |  |                |             |                 
|TOTAL CURRENT ASSETS                                             |  |                | 152,649     |                 
|                                                                 |  |                |             |                 
|PROPERTY AND EQUIPMENT                                           |  |                |             |                 
|Capital equipment                                                |  |                | 32,604      |                 
|Less accumulated depreciation                                    |  |                | 32,604      |                 
|                                                                 |  |                | —           |                 
|                                                                 |  |                |             |                 
|Patent costs, net of accumulated amortization of                 |  |                |             |                 
|$81,619 and $78,851 as of March 31, 2012                         |  |                |             |                 
|and December 31, 2011                                            |  |                | 115,850     |                 
|                                                                 |  |                |             |                 
|TOTAL ASSETS                                                     |  | $              | 268,499     |                 
|                                                                 |  |                |             |                 
|LIABILITIES AND STOCKHOLDERS' DEFICIT                            |  |                |             |                 
|                                                                 |  |                |             |                 
|CURRENT LIABILITIES                                              |  |                |             |                 
|Accounts payable and accrued expenses                            |  | $              | 1,748,005   |                 
|Notes payable                                                    |  |                | 50,000      |                 
|                                                                 |  |                |             |                 
|TOTAL CURRENT LIABILITIES                                        |  |                | 1,798,005   |                 
|                                                                 |  |                |             |                 
|LONG-TERM LIABILITIES                                            |  |                |             |                 
|Senior secured convertible notes payable                         |  |                | 781,500     |                 
|Convertible notes payable                                        |  |                | 140,000     |                 
|Notes payable, net of discount of $17,350 and $18,589 as of      |  |                |             |                 
|March 31, 2012 and December 31, 2011                             |  |                | 1,093,650   |                 
|                                                                 |  |                |             |                 
|TOTAL LONG-TERM LIABILITIES                                      |  |                | 2,015,150   |                 
|                                                                 |  |                |             |                 
|STOCKHOLDERS' DEFICIT                                            |  |                |             |                 
|                                                                 |  |                |             |                 
|Preferred Stock, $ .001 par value; 75,000,000 shares authorized; |  |                |             |                 
|no shares issued and outstanding                                 |  |                | —           |                 
|Common stock, $ .001 par value; 175,000,000 shares authorized;   |  |                |             |                 
|174,940,506 shares issued and 145,144,603 outstanding at         |  |                |             |                 
|March 31, 2012 and December 31, 2011                             |  |                | 174,940     |                 
|                                                                 |  |                |             |                 
|Additional paid in capital                                       |  |                | 8,817,382   |                 
|                                                                 |  |                |             |                 
|Treasury stock (29,795,903 shares at March 31, 2012              |  |                |             |                 
|and December 31, 2011), at cost                                  |  |                | (113,389    | )               
|                                                                 |  |                |             |                 
|Deficit accumulated during the development stage                 |  |                | (12,423,589 | )               
|                                                                 |  |                |             |                 
|STOCKHOLDERS' DEFICIT                                            |  |                | (3,544,656  | )               
|                                                                 |  |                |             |                 
|TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT                      |  | $              | 268,499     |                 









See
the accompanying notes to the condensed consolidated financial statements.







LaserLock
Technologies, Inc. and Subsidiary

(A
Development Stage Company)

Condensed
Consolidated Statements of Operations (Unaudited)

For
the Three Months Ended March 31, 2012 and 2011

And
for the Period November 10, 1999 (Date of Inception) to March 31, 2012







|                                   |  |            |             | Three Months |  | Three Months
|---------------------------------- |  | ---------- | ----------- | ------------ |  | ------------
|                                   |  | Cumulative |             | Ended        |  | Ended       
|                                   |  | Since      |             | March 31,    |  | March 31,   
|                                   |  | Inception  |             | 2012         |  | 2011        
|                                   |  |            |             |              |  |             
|NET REVENUES                       |  |            |             |              |  |             
|Sales                              |  | $          | 457,866     |              |  | $           
|Royalties                          |  |            | 645,180     |              |  |             
|                                   |  |            |             |              |  |             
|TOTAL NET REVENUE                  |  |            | 1,103,046   |              |  |             
|                                   |  |            |             |              |  |             
|COST OF SALES                      |  |            | 426,984     |              |  |             
|                                   |  |            |             |              |  |             
|GROSS PROFIT                       |  |            | 676,062     |              |  |             
|                                   |  |            |             |              |  |             
|OPERATING EXPENSES                 |  |            |             |              |  |             
|Research and development           |  |            | 863,629     |              |  |             
|Patent costs                       |  |            | 65,000      |              |  |             
|Legal and Accounting               |  |            | 1,352,359   |              |  |             
|Sales and Marketing                |  |            | 5,479,277   |              |  |             
|General and administrative         |  |            | 3,772,245   |              |  |             
|Total operating expenses           |  |            | 11,532,510  |              |  |             
|                                   |  |            |             |              |  |             
|LOSS BEFORE OTHER INCOME           |  |            | (10,856,448 | )            |  |             
|                                   |  |            |             |              |  |             
|OTHER INCOME (EXPENSE)             |  |            |             |              |  |             
|Interest income                    |  |            | 63,663      |              |  |             
|Interest expense                   |  |            | (1,984,768  | )            |  |             
|Gain on debt forgiveness           |  |            | 184,242     |              |  |             
|Gain on disposition of assets      |  |            | 4,722       |              |  |             
|                                   |  |            | (1,732,141  | )            |  |             
|                                   |  |            |             |              |  |             
|LOSS BEFORE INCOME TAX BENEFIT     |  |            | (12,588,589 | )            |  |             
|                                   |  |            |             |              |  |             
|INCOME TAX BENEFIT                 |  |            | (165,000    | )            |  |             
|                                   |  |            |             |              |  |             
|NET LOSS                           |  | $          | (12,423,589 | )            |  | $           
|                                   |  |            |             |              |  |             
|BASIC AND DILUTED NET LOSS PER     |  |            |             |              |  |             
|COMMON SHARE                       |  |            |             |              |  | $           
|                                   |  |            |             |              |  |             
|BASIC AND DILUTED WEIGHTED AVERAGE |  |            |             |              |  |             
|COMMON SHARES OUTSTANDING          |  |            |             |              |  |             



See
the accompanying notes to the condensed consolidated financial statements.







LaserLock
Technologies, Inc. and Subsidiary

(A
Development Stage Company)

Condensed
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited)

For
the Period November 10, 1999 (Date of Inception) to March 31, 2012

















|                                                                 |                  |                          |                             |          |           | Deficit Accumulated During the Development Stage |            
|---------------------------------------------------------------- | ---------------- | ------------------------ | --------------------------- | -------- | --------- | ------------------------------------------------ | -----------
|                                                                 | Common Stock     |                          |                             |          |          
|                                                                 |                  | Deferred Consulting Fees | Additional Paid- In Capital |         
|                                                                 | Number of Shares |                          | Treasury Stock              |         
|                                                                 | Amount           | Total                   
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Issuance of initial 4,278,000 shares on November 10, 1999        | 4,278,000        | 4,278                    | -                           | -        | 16,595    | -                                                | 20,873     
|Issuance of shares of common stock in exchange for services      | 1,232,000        | 1,232                    | -                           | -        | 35,728    | -                                                | 36,960     
|Issuance of shares of common stock                               | 2,090,000        | 2,090                    | -                           | -        | 60,610    | -                                                | 62,700     
|Stock issuance costs                                             | -                | -                        | -                           | -        | (13,690)  | -                                                | (13,690)   
|Net loss                                                         | -                | -                        | -                           | -        | -         | (54,113)                                         | (54,113)   
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Balance, December 31, 1999                                       | 7,600,000        | 7,600                    | -                           | -        | 99,243    | (54,113)                                         | 52,730     
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Issuance of shares of common stock                               | 5,449,999        | 5,450                    | -                           | -        | 921,050   | -                                                | 926,500    
|Issuance of shares of common stock in exchange for services      | 240,000          | 240                      | -                           | (40,800) | 40,560    | -                                                | -          
|Stock issuance costs                                             | -                | -                        | -                           | -        | (16,335)  | -                                                | (16,335)   
|Fair value of non-employee stock options grants                  | -                | -                        | -                           | -        | 50,350    | -                                                | 50,350     
|Amortization of deferred consulting fees                         | -                | -                        | -                           | 20,117   | -         | -                                                | 20,117     
|Net loss                                                         | -                | -                        | -                           | -        | -         | (367,829)                                        | (367,829)  
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Balance, December 31, 2000                                       | 13,289,999       | 13,290                   | -                           | (20,683) | 1,094,868 | (421,942)                                        | 665,533    
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Issuance of shares of common stock                               | 217,500          | 218                      | -                           | -        | 77,723    | -                                                | 77,941     
|Issuance of shares of common stock and stock options for         |                  |                          |                             |          |           |                                                  |            
|acquisition of subsidiary                                        | 2,000,000        | 2,000                    | -                           | -        | 736,000   | -                                                | 738,000    
|Issuance of stock options                                        | -                | -                        | -                           | -        | 15,000    | -                                                | 15,000     
|Exercise of options                                              | 1,450,368        | 1,450                    | -                           | -        | 230,609   | .                                                | 232,059    
|Fair value of non-employee stock options                         | -                | -                        | -                           | -        | 323,250   | -                                                | 323,250    
|Amortization of deferred consulting fees                         | -                | -                        | -                           | 20,683   | -         | -                                                | 20,683     
|Net loss                                                         | -                | -                        | -                           | -        | -         | (1,052,299)                                      | (1,052,299)
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Balance, December 31, 2001                                       | 16,957,867       | 16,958                   | -                           | -        | 2,477,450 | (1,474,241)                                      | 1,020,167  
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Issuance of shares of common stock                               | 3,376,875        | 3,377                    | -                           | -        | 687,223   | -                                                | 690,600    
|Fair value of non-employee stock options                         | -                | -                        | -                           | -        | 94,000    | -                                                | 94,000     
|Salary due to shareholder contributed capital                    | -                | -                        | -                           | -        | 15,000    | -                                                | 15,000     
|Return of shares of common stock related to purchase price       |                  |                          |                             |          |           |                                                  |            
|adjustment                                                       | (1,000,000)      | (1,000)                  | -                           | -        | (353,000) | -                                                | (354,000)  
|Net loss                                                         | -                | -                        |                             |          | -         | (1,195,753)                                      | (1,195,753)
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Balance, December 31, 2002                                       | 19,334,742       | 19,335                   | -                           | -        | 2,920,673 | (2,669,994)                                      | 270,014    
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Issuance of shares of common stock                               | 22,512,764       | 22,512                   | -                           | -        | 1,387,109 | -                                                | 1,409,621  
|Fair value of non-employee stock options                         | -                | -                        | -                           | -        | 213,300   |                                                  | 213,300    
|Issuance of shares of common stock in exchange for services      | 143,000          | 143                      | -                           | -        | 23,857    |                                                  | 24,000     
|Stock issuance costs                                             | -                | -                        | -                           | -        | (49,735)  |                                                  | (49,735)   
|Net loss                                                         | -                | -                        | -                           | -        | -         | (1,107,120)                                      | (1,107,120)
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Balance, December 31, 2003                                       | 41,990,506       | 41,990                   | -                           | -        | 4,495,204 | (3,777,114)                                      | 760,080    
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Stock issuance costs                                             | -                | -                        | -                           | -        | (25,000)  | -                                                | (25,000)   
|Fair value of non-employee stock options                         | -                | -                        | -                           | -        | 493,600   | -                                                | 493,600    
|Issuance of shares of common stock                               | 18,600,000       | 18,600                   | -                           | -        | 939,881   | -                                                | 958,481    
|Net loss                                                         | -                | -                        | -                           | -        | -         | (1,406,506)                                      | (1,406,506)
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Balance, December 31, 2004                                       | 60,590,506       | 60,590                   | -                           | -        | 5,903,685 | (5,183,620)                                      | 780,655    
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Fair value of non-employee stock options                         | -                | -                        | -                           | -        | 286,762   | -                                                | 286,762    
|Issuance of shares of common stock                               | 3,000,000        | 3,000                    | -                           | -        | 102,000   | -                                                | 105,000    
|Net loss for the year ended December 31, 2005                    | -                | -                        | -                           | -        | -         | (1,266,811)                                      | (1,266,811)
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Balance at December 31, 2005                                     | 63,590,506       | 63,590                   | -                           | -        | 6,292,447 | (6,450,431)                                      | (94,394)   
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Fair value of non-employee stock options                         | -                | -                        | -                           | -        | 215,463   | -                                                | 215,463    
|Fair value of employee stock options                             | -                | -                        | -                           | -        | 135,098   | -                                                | 135,098    
|Fair value of warrants issued for deferred finance charges       | -                | -                        | -                           | -        | 392,376   | -                                                | 392,376    
|Exercise of warrants                                             | 5,550,000        | 5,550                    | -                           | -        | 49,950    | -                                                | 55,500     
|Exercise of options                                              | 4,300,000        | 4,300                    | -                           | -        | (3,870)   | -                                                | 430        
|Shares retired upon cancellation of consulting agreements        | (1,200,000)      | (1,200)                  | -                           | -        | 1,080     | -                                                | (120)      
|Issuance of shares for services                                  | 1,200,000        | 1,200                    |                             |          | 53,800    |                                                  | 55,000     
|Net loss for the year ended December 31, 2006                    | -                | -                        | -                           | -        | -         | (1,607,017)                                      | (1,607,017)
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Balance at December 31, 2006                                     | 73,440,506       | 73,440                   | -                           | -        | 7,136,344 | (8,057,448)                                      | (847,664)  
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Fair value of non-employee stock options                         | -                | -                        | -                           | -        | 47,692    | -                                                | 47,692     
|Fair value of employee stock options                             | -                | -                        | -                           | -        | 67,651    | -                                                | 67,651     
|Recognition of beneficial conversion feature                     | -                | -                        | -                           | -        | 375,000   | -                                                | 375,000    
|Net loss for the year ended December 31, 2007                    | -                | -                        | -                           | -        |           | (1,117,334)                                      | (1,117,334)
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Balance at December 31, 2007                                     | 73,440,506       | 73,440                   | -                           | -        | 7,626,687 | (9,174,782)                                      | (1,474,655)
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Fair value of non-employee stock options                         | -                | -                        | -                           | -        | 28,752    | -                                                | 28,752     
|Fair value of employee stock options                             | -                | -                        | -                           | -        | 19,720    | -                                                | 19,720     
|Fair value of warrants issued in conjunction with debt financing | -                | -                        | -                           | -        | 25,000    |                                                  | 25,000     
|Net loss for the year ended December  31, 2008                   | -                | -                        | -                           | -        | -         | (931,338)                                        | (931,338)  
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Balance at December 31, 2008                                     | 73,440,506       | 73,440                   | -                           | -        | 7,700,159 | (10,106,120)                                     | (2,332,521)
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Fair value of non-employee stock options                         | -                | -                        | -                           | -        | 1,524     | -                                                | 1,524      
|Fair value of warrants issued in conjunction with debt financing | -                | -                        | -                           | -        | 15,450    |                                                  | 15,450     
|Issuance of shares for services                                  | 7,200,000        | 7,200                    | -                           | -        | 40,500    | -                                                | 47,700     
|Shares issued for conversion of notes payable                    | 48,750,000       | 48,750                   | -                           | -        | 263,291   | -                                                | 312,041    
|Net loss for the year ended December  31, 2009                   | -                | -                        | -                           | -        | -         | (694,910)                                        | (694,910)  
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Balance at December 31, 2009                                     | 129,390,506      | 129,390                  | -                           | -        | 8,020,924 | (10,801,030)                                     | (2,650,716)
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Fair value of non-employee stock options                         | -                | -                        | -                           | -        | 364       | -                                                | 364        
|Fair value of warrants issued in conjunction with debt financing | -                | -                        | -                           | -        | 20,143    | -                                                | 20,143     
|Issuance of shares for services                                  | 25,950,000       | 25,950                   | -                           | -        | 182,650   | -                                                | 208,600    
|Net loss for the year ended Decemberr 31, 2010                   | -                | -                        | -                           | -        | -         | (721,841)                                        | (721,841)  
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Balance at December 31, 2010                                     | 155,340,506      | 155,340                  | -                           | -        | 8,224,081 | (11,522,871)                                     | (3,143,450)
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Issuance of shares for services                                  | 1,000,000        | 1,000                    | -                           | -        | 29,000    | -                                                | 30,000     
|Contribution of common stock from related parties                | (12,000,000)     | -                        | (95,594)                    | -        | 95,594    | -                                                | -          
|Purchase of common stock for treasury                            | (17,795,903)     | -                        | (17,795)                    | -        | -         | -                                                | (17,795)   
|Sale of common stock                                             | 15,500,000       | 15,500                   | -                           | -        | 384,500   | -                                                | 400,000    
|Issuance of shares for stock issuance costs                      | 2,100,000        | 2,100                    | -                           | -        | (2,100)   | -                                                | -          
|Stock issuance costs                                             | -                | -                        | -                           | -        | (40,000)  | -                                                | (40,000)   
|Exercise of options                                              | 1,000,000        | 1,000                    |                             | -        | 9,000     | -                                                | 10,000     
|Fair value of warrants issued in conjunction with debt financing | -                | -                        | -                           | -        | 21,275    | -                                                | 21,275     
|Fair value of employee stock options                             | -                | -                        | -                           | -        | 47,658    | -                                                | 47,658     
|Fair value of non-employee stock options                         | -                | -                        |                             | -        | 48,374    | -                                                | 48,374     
|Net loss for the year ended December 31, 2011                    | -                | -                        | -                           | -        | -         | (665,113)                                        | (665,113)  
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Balance at December 31, 2011                                     | 145,144,603      | 174,940                  | (113,389)                   | -        | 8,817,382 | (12,187,984)                                     | (3,309,051)
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Net loss for the three months ended March 31, 2012               | -                | -                        | -                           | -        | -         | (235,605)                                        | (235,605)  
|                                                                 |                  |                          |                             |          |           |                                                  |            
|Balance at March 31, 2012                                        | 145,144,603      | 174,940                  | (113,389)                   | -        | 8,817,382 | (12,423,589)                                     | (3,544,656)











See
the accompanying notes to the condensed consolidated financial statements.













LaserLock
Technologies, Inc. and Subsidiary

(A
Development Stage Company)

Condensed
Consolidated Statements of  Cash Flows(Unaudited)

For
the Period November 10, 1999 (Date of Inception) to March 31, 2012







|                                                           |  |            |            | Three Months |  | Three Months
|---------------------------------------------------------- |  | ---------- | ---------- | ------------ |  | ------------
|                                                           |  | Cumulative |            | Ended        |  | Ended       
|                                                           |  | Since      |            | March 31,    |  | March 31,   
|                                                           |  | Inception  |            | 2012         |  | 2011        
|CASH FLOWS FROM OPERATING ACTIVITIES                       |  |            |            |              |  |             
|Net cash used in operating activities                      |  | $          | (6,705,988 | )            |  | $           
|                                                           |  |            |            |              |  |             
|CASH FLOWS FROM INVESTING ACTIVITIES                       |  |            |            |              |  |             
|Purchase of property and equipment                         |  |            | (35,749    | )            |  |             
|Purchase of intangibles                                    |  |            | (20,000    | )            |  |             
|Purchase of patent costs                                   |  |            | (197,469   | )            |  |             
|Proceeds from sale of assets                               |  |            | 6,738      |              |  |             
|                                                           |  |            |            |              |  |             
|Net cash used in investing activities                      |  |            | (246,480   | )            |  |             
|                                                           |  |            |            |              |  |             
|CASH FLOWS FROM FINANCING ACTIVITIES                       |  |            |            |              |  |             
|Proceeds from issuance of common stock                     |  |            | 4,491,447  |              |  |             
|Proceeds from exercise of stock options                    |  |            | 242,369    |              |  |             
|Proceeds from issuance of stock options                    |  |            | 15,000     |              |  |             
|Proceeds from exercise of warrants                         |  |            | 55,500     |              |  |             
|Proceeds from issuance of notes                            |  |            | 2,589,000  |              |  |             
|Repayments of notes                                        |  |            | (196,500   | )            |  |             
|Payment for treasury stock                                 |  |            | (17,795    | )            |  |             
|Debt issuance costs                                        |  |            | (62,000    | )            |  |             
|Stock issuance costs                                       |  |            | (144,760   | )            |  |             
|                                                           |  |            |            |              |  |             
|Net cash provided by financing activities                  |  |            | 6,972,261  |              |  |             
|                                                           |  |            |            |              |  |             
|NET DECREASE IN CASH AND                                   |  |            |            |              |  |             
|CASH EQUIVALENTS                                           |  |            | 19,793     |              |  |             
|                                                           |  |            |            |              |  |             
|CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD            |  |            | —          |              |  |             
|                                                           |  |            |            |              |  |             
|CASH AND CASH EQUIVALENTS - END OF PERIOD                  |  | $          | 19,793     |              |  | $           
|                                                           |  |            |            |              |  |             
|SUPPLEMENTAL DISCLOSURE OF NON-CASH                        |  |            |            |              |  |             
|INVESTING AND FINANCING ACTIVITIES:                        |  |            |            |              |  |             
|Cash paid during the year for:                             |  |            |            |              |  |             
|Interest                                                   |  | $          | 39,440     |              |  | $           
|                                                           |  |            |            |              |  |             
|Income taxes                                               |  | $          | —          |              |  | $           
|                                                           |  |            |            |              |  |             
|Return of shares of common stock related to                |  |            |            |              |  |             
|purchase price adjustment                                  |  |            |            |              |  |             
|Common stock                                               |  |            | (1,000     | )            |  |             
|Additional paid-in capital                                 |  |            | (353,000   | )            |  |             
|                                                           |  |            |            |              |  |             
|Intangible assets                                          |  | $          | (354,000   | )            |  | $           
|                                                           |  |            |            |              |  |             
|Issuance of common stock and stock options                 |  |            |            |              |  |             
|for acquisition of subsidiary                              |  | $          | 738,000    |              |  | $           
|                                                           |  |            |            |              |  |             
|Proceeds from common stock sales applied directly          |  |            |            |              |  |             
|to debt and financing expenses repayment                   |  | $          | 55,270     |              |  | $           
|                                                           |  |            |            |              |  |             
|Fair value of warrants issued for deferred finance charges |  | $          | 392,376    |              |  | $           
|                                                           |  |            |            |              |  |             
|Fair value of stock issued for conversion of notes payable |  | $          | 312,041    |              |  | $           
|                                                           |  |            |            |              |  |             
|Fair value of beneficial conversion option                 |  | $          | 400,000    |              |  | $           
|                                                           |  |            |            |              |  |             
|Fair value of warrants issued as debt discount             |  | $          | 78,043     |              |  | $           
|                                                           |  |            |            |              |  |             
|Issuance of common stock for stock issuance costs          |  | $          | 2,100      |              |  | $           
|                                                           |  |            |            |              |  |             
|Issuance of options as stock cost for treasury stock       |  | $          | 5,594      |              |  | $           













See
the accompanying notes to the condensed consolidated financial statements.

LaserLock
Technologies, Inc. and Subsidiaries

(A
Development Stage Company)

Notes
to Condensed Consolidated Financial Statements (Unaudited)



NOTE
1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES



Basis
of Presentation

The
financial statements are presented in accordance with Financial Accounting Standards Board Accounting Standards Codification (“FASB
ASC”) 915 for development stage entities.  The accompanying unaudited financial statements have been prepared
in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions for
Form 10-Q and Rule 8-03 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required
by generally accepted accounting principles for complete financial statements.  In the opinion of management, all adjustments
(consisting of normal recurring accruals) considered necessary for a fair presentation have been included. The financial statements
should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on form 10-K
for the year ended December 31, 2011 as filed with the Securities and Exchange Commission.  Operating results for the
three months ended March 31, 2012 are not necessarily indicative of the results that may be expected for the year ended December
31, 2012.



Comprehensive
Income

The
Company follows FASB ASC 220 in reporting comprehensive income.  Comprehensive income is a more inclusive financial
reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the
calculation of net income.  Since the Company has no items of other comprehensive loss, comprehensive loss is equal
to net loss.



Fair
Value of Financial Instruments

The
Company’s financial instruments consist of cash, accounts receivable, accounts payable and accrued expenses and notes payable.  The
carrying value of cash, accounts receivable, accounts payable and accrued expenses because of their short maturities. The Company
believes the carrying amount of its notes payable and convertible debt approximates its fair value based on rates and other terms
currently available to the Company for similar debt instruments. The Company classifies the fair value of its notes payable and
convertible debt within level 2 of the fair value hierarchy based on observable inputs used to estimate fair value.



Loss
Per Share

The
Company follows FASB ASC 260 when reporting Earnings Per Share resulting in the presentation of basic and diluted earnings per
share.  Because the Company reported a net loss for the three months ended March 31, 2012 and 2011, common stock equivalents,
including convertible debt, stock options and warrants were anti-dilutive; therefore, the amounts reported for basic and dilutive
loss per share were the same.



Segment
Information

The
Company is organized and operates as one operating segment wherein the Company’s patented technologies are utilized to address
counterfeiting issues primarily in the gaming industry. In accordance with FASB ASC 280, Segment Reporting, the chief operating
decision-maker has been identified as the Chief Executive Officer, who reviews operating results to make decisions about allocating
resources and assessing performance for the entire Company.  Since the Company operates in one segment and provides one group
of similar products, all financial segment and product line information required by FASB ASC 280 can be found in the condensed
consolidated financial statements.











LaserLock
Technologies, Inc. and Subsidiary

(A
Development Stage Company)

Notes
to Condensed Consolidated Financial Statements (Unaudited)



NOTE
1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)



Recently
Adopted Accounting Pronouncements

In
May 2011, the FASB issued ASU No. 2011-04 (“ASC Update 2011-04”), Amendments to Achieve Common Fair Value
Measurements and Disclosure Requirements in U.S. GAAP and IFRS. This ASU is intended to update the fair value measurement
and disclosure requirements in US GAAP for measuring fair value and for disclosing information about fair value measurements.  Some
of the amendments clarify the Board’s intent about application of existing fair value measurement requirements, while others
change a particular principle or requirement for measuring or disclosing fair value measurement information.  The amendments
in this update are for interim and annual periods beginning after December 15, 2011.  The Company adopted the provisions
of this ASU, and the required changes in presentation and disclosure requirements have been included in the March 31, 2012 financial
statements.  The adoption did not have a material impact on the Company’s condensed consolidated financial position,
results of operations or cash flows.



Recently
Issued Accounting Pronouncements Not Yet Adopted

As
of March 31, 2012, there are no recently issued accounting standards not yet adopted which would have a material effect on the
Company’s condensed consolidated financial statements.



NOTE
2 – GOING CONCERN



The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going
concern. The Company has incurred significant losses and experienced negative cash flow during the development stage. These conditions
raise substantial doubt about the Company’s ability to continue as a going concern. The condensed consolidated financial
statements do not include any adjustments that might result from the outcome of this uncertainty.



Since
inception, the Company has focused on developing and implementing our business plan. The Company has not recently paid salaries
to management and is utilizing subcontractors on a work for hire basis to continue the operations of the Company. The Company
believes that its existing cash resources will not be sufficient to sustain operations during the next twelve months. The Company
intends to raise funds through the sale of debt and equity securities. The issuance of additional equity would result in dilution
to the existing shareholders. If the Company is unable to obtain additional funds when they are needed or if such funds cannot
be obtained on terms acceptable to the Company, the Company may be unable to execute upon the business plan or pay costs and expenses
as they are incurred, which could have a material adverse effect on the business, financial condition and results of operations.



Even
if the Company is successful in raising sufficient capital to complete the development of its products, the Company’s ability
to continue in business as a viable going concern can only be achieved when revenues reach a level that sustains business operations.
If sufficient funding cannot be obtained in the short term, the Company will need to reduce monthly expenditures to a level that
will enable the Company to continue until such funds can be obtained.



The
Company is in the development stage at March 31, 2012. Successful completion of the Company’s development program and, ultimately
the attainment of profitable operations are dependent upon future events, including obtaining adequate financing to fulfill its
development activities and achieving a level of sales adequate to support the Company’s cost structure. However, there can
be no assurances that the Company will be able to secure additional debt financing or equity investment or achieve an adequate
sales level.









LaserLock
Technologies, Inc. and Subsidiary

(A
Development Stage Company)

Notes
to Condensed Consolidated Financial Statements (Unaudited)



NOTE
3 – PATENTS



The
Company has five issued patents for anti-counterfeiting technology. Accordingly, costs associated with the registration of these
patents and legal defense have been capitalized and are amortized on a straight-line basis over the estimated lives of the patents
(17 years). Amortization expense for patents was $2,768 and $2,715 for the three months ended March 31, 2012 and 2011, respectively.
Future estimated amortization for the remaining nine months ending December 31, 2012 is $8,000. Future estimated annual amortization
over the next five years is approximately $11,000 per year for the years ending December 31, 2013 through 2017.



NOTE
4 - SENIOR SECURED CONVERTIBLE NOTES PAYABLE



In
February 2006, the Company commenced a private placement of up to $800,000 principal amount of 10% senior secured convertible
promissory notes due twelve months from the date of issue to certain Company shareholders and other accredited investors. As of
December 31, 2006, the Company completed this private placement by selling all notes payable totaling $800,000. The notes are
secured by a first priority lien on all of the tangible and intangible personal property of the Company. In May 2007, the due
date of these notes was extended to August 2008 and the interest rate increased to 12% annum during the extension period. In June
2011, the due date of $90,000 of these notes was extended to September 2013, $95,000 of the notes was extended to September 2014
and the due date of $596,500 of the notes was extended to September 2015. The interest rate associated with $762,500 of the extended
notes in June 2011 is 10% per annum, while the remaining $19,000 is at 12% per annum. As of March 31, 2012 and December 31, 2011,
the outstanding principal balance on these notes was $781,500. Accrued interest at March 31, 2012 and December 31, 2011 amounted
to $541,298 and $521,665, respectively. Interest expense for the three months ended March 31, 2012 and 2011 was $19,633 and $24,000,
respectively.



Purchasers
of the notes were issued 8,000,000 10-year warrants exercisable into the Company’s shares of common stock at an exercise
price of $0.01 per share. The warrants were valued at $392,376 and recorded as a debt discount on the notes payable. The Company
used the Black-Scholes option pricing model to calculate the grant-date fair value of the warrants, with the following assumptions:
no dividend yield, expected volatility of 169% and 284%, risk-free interest rate between 3.6% and 4.5% and expected warrant life
of ten years. The deferred finance charges were amortized over one year, which was the original term of the notes. As of March
31, 2012, the Company has received $70,000 for the exercise of 7,000,000 of the warrants.



In
addition, if an equity financing with total proceeds of more than $5,000,000 occurs while any notes are outstanding, holders of
notes will have the right, at their option, to convert the outstanding principal and interest of the notes into shares at a discount
of 30% of the price per share in the qualified financing. Since the embedded conversion feature is contingent upon the occurrence
of the qualified financing, the value of the contingent conversion feature, if beneficial, will be recognized when the triggering
event occurs and the contingency is resolved.









LaserLock
Technologies, Inc. and Subsidiary

(A
Development Stage Company)

Notes
to Condensed Consolidated Financial Statements (Unaudited)



NOTE
5 - CONVERTIBLE NOTES PAYABLE



During
2007, the Company commenced a private placement of up to $400,000 principal amount of10% Convertible Promissory Notes
originally due in August 2008 (the “Notes”). The Company raised $375,000 under this private placement in 2007 and
the remaining $25,000 was raised in 2008. Holders of Notes will have the right, at their option, to convert the outstanding principal
and interest of the Notes into shares of the Company’s Series A Preferred Stock at any time and from time to time at the
option of the holder at the initial conversion price of $0.005333 per share. The Notes are unsecured.



In
June 2011, the noteholder of the $140,000 under this convertible note issue agreed to extend the maturity date of these notes
to September 30, 2015 at an interest rate of 10% per annum. Additionally, the noteholder agreed in writing to suspend its right
to convert its notes until such time as the Company’s authorized shares have been increased. Remaining shares to be potentially
issued under this convertible note issue are 26,250,000.



As
of March 31, 2012 and December 31, 2011, the remaining principal balance on the notes was $140,000.  Accrued interest at
March 31, 2012 and December 31, 2011 amounted to $68,250 and $64,750, respectively. Interest expense for the three months ended
March 31, 2012 and 2011 was $3,500 for both periods.



NOTE
6 - NOTES PAYABLE



Notes
payable consists of the following:



|                                                                                                                                                   | March
    31, 2012 | December
    31, 2012
|-------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------ | ---------------------
|Unsecured
    notes payable; interest at 10% per annum; principal and accrued interest due at maturity from April 2013 through  September
    2015 | $561,000           | $561,000             
|Series
        A notes payable; interest at 8% per annum; principal and accrued interest due at extended maturity date in September 2015           | 150,000            | 150,000              
|Series
        A notes payable; interest at 8% per annum; principal and accrued interest due at maturity in October 2011 (past due)                | 50,000             | 50,000               
|Notes
        payable, interest at 25% per annum; principal and interest due September 2013                                                        | 400,000            | 400,000              
|Less:
        Debt discount                                                                                                                        | (17,350)           | (18,589)             
|                                                                                                                                                   | 1,143,650          | 1,142,411            
|Less:
    Current portion                                                                                                                          | 50,000             | 50,000               
|Long-term
    portion                                                                                                                              | $1,093,650         | $1,092,411           
|                                                                                                                                                   |                    |                      









LaserLock
Technologies, Inc. and Subsidiary

(A
Development Stage Company)

Notes
to Condensed Consolidated Financial Statements (Unaudited)



NOTE
6 - NOTES PAYABLE (Continued)



At
March 31, 2012 and December 31, 2011, accrued interest on notes payable was $405,831 and $362,806, respectively. Interest
expense for the three months ended March 31, 2012 and 2011 was $43,025 and $44,650 respectively.



Private
Placement of 8% Series A Notes Payable

In
August 2009, the Company commenced a private placement of up to $300,000 consisting of up to six units. Each unit consists of
a $50,000, 8% Series A Note Payable, due September 30, 2011, and a non-detachable warrant to purchase two million shares of the
Company’s common stock. During 2009, the Company sold four units, issued $200,000 of 8% Series A Notes Payable, issued eight
million warrants, and raised $180,000, net of commission of $20,000. In January 2010, the Company sold 0.5 units, issued $25,000
of 8% Series A Notes Payable, issued one million warrants, and raised $17,500 net of commissions of $7,500. The commissions were
treated as deferred finance charges and are expensed over the term of notes payable. For the three months ended March 31, 2011,
amortization of deferred finance charges was $7,682. No amortization was recorded for the three months ended March 31, 2012, since
the deferred finance charges were fully amortized as of December 31, 2011.



In
June 2011, the maturity date on the $150,000 of the 8% Series A Notes Payable and the term on the associated six million warrants
were extended to September 30, 2015. As a result, the warrants were revalued using the Black-Scholes option pricing model to calculate
the incremental fair-value of the warrants of $21,275, with the following assumptions: no dividend yield, expected volatility
of 60%, risk free interest rate of 1.52% and warrant life of approximately 1.25 years. As part of the debt extension, the lender
holding the six million warrants agreed in writing to suspend its right to exercise these warrants until such time that the Company’s
authorized shares have been increased.



The
relative fair value of the warrants issued in conjunction with the 8% Series A Notes Payable have been treated as a debt discount
with an offsetting credit to additional paid-in capital. The debt discount related to the warrant issuances are being accreted
to interest expense over the term of the notes. When the warrants were revalued the incremental amount of $21,275 was also treated
as additional debt discount and is being accreted over the new term of the 8% Series A Notes Payable. As of March 31, 2012 and
December 31, 2011, the unaccreted debt discount related to warrants issued in conjunction with the 8% Series A Notes payable was
$17,350 and $18,589, respectively. For the three months ended March 31, 2012 and 2011, accreted interest expense from the accretion
of the debt discount was $1,239 and $4,910, respectively.













LaserLock
Technologies, Inc. and Subsidiary

(A
Development Stage Company)

Notes
to Condensed Consolidated Financial Statements (Unaudited)



NOTE
6 – NOTES PAYABLE (Continued)



Private
Placement of 25% Notes Payable

In
2010, the Company issued $400,000 in notes payable in order to finance a patent infringement lawsuit (see Note 10 - Subsequent
Events to these condensed consolidated financial statements). The notes payable accrue interest at 25% per annum and mature upon
the earlier of September 1, 2013 or the date on which the Company receives net proceeds from the patent infringement claim. In
addition to the base interest of 25% per annum, interest, accruing to maturity the lenders are entitled to Bonus Interest equal
to the following:



| | a. | First monies
    realized by the Company from its share of the net proceeds of the lawsuit shall be allocated and paid to the Lender until
    the principal and base interest accruing has been fully paid.
| | -- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | b. | The next monies
    from the net proceeds of the litigation settlement will be paid to the Company to reimburse for out-of-pocket legal costs
    related to the lawsuit.
| | -- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | c. | The next $825,000
    of proceeds will be split 50%/50% between the Company and the Lenders.
| | -- | --------------------------------------------------------------------------------------------



| | d. | The next $1
    million realized by the Company shall be allocated 90% to the Company and 10% to the Lenders.
| | -- | -------------------------------------------------------------------------------------------------------------



| | e. | The next $1
    million realized by Company shall be allocated 85% to Company and 15% to Lenders.
| | -- | -------------------------------------------------------------------------------------------------



| | f. | All remaining
    proceeds realized by Company shall be allocated 80% to Company and 20% to Lenders.
| | -- | ----------------------------------------------------------------------------------------------------



The
Lenders have a security interest in the Company's patent infringement claim in which the Lender has the right to the net proceeds
of this lawsuit to satisfy outstanding principal and interest under the notes.



As
part of the private placement of the 25% notes payable, the Company incurred debt placement fees of $34,500 in 2010. These debt
placement fees have been treated as deferred finance charges and are being amortized to interest expense over the life of the
notes payable. For the three months ended March 31, 2012 and 2011, amortization of deferred finance charges was $4,313 for both
periods.



Aggregate
Maturities of Long-term Debt

Aggregate
maturities of the senior secured convertible notes, convertible notes and notes payable over the next five years are as follows:



|2012 |  | 50,000    | 
|---- |  | --------- | 
|2013 |  | 490,000   | 
|2014 |  | 95,000    | 
|2015 |  | 1,447,500 | 
|2016 |  | -         | 













LaserLock
Technologies, Inc. and Subsidiary

(A
Development Stage Company)

Notes
to Condensed Consolidated Financial Statements (Unaudited)



NOTE
7 – STOCK OPTIONS AND WARRANTS



During
1999, the Board of Directors (“Board”) of the Company adopted, with the approval of the stockholders, a Stock Option
Plan. In 2000, the Board superseded that plan and created a new Stock Option Plan, pursuant to which it is authorized to grant
options to purchase up to 1.5 million shares of common stock. On December 17, 2003, the Board, with approval of the stockholders,
superseded this plan and created the 2003 Stock Option Plan (the “Plan”). Under the Plan the Company is authorized
to grant options to purchase up to 18,000,000 shares of common stock to the Company’s employees, officers, directors, consultants,
and other agents and advisors. The Plan is intended to permit stock options granted to employees under the Plan to qualify as
incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended (“Incentive Stock Options”).
All options granted under the Plan, which are not intended to qualify as Incentive Stock Options, are deemed to be non-qualified
options (“Non-Statutory Stock Options”). As of March 31, 2012, there were 3,100,000 options that had been issued and
exercised, 13,625,996 options that had been issued and were unexercised, and 1,274,004 options that were available to be issued
under the Plan.



The
Plan is administered by a committee of the Board of Directors (“Stock Option Committee”) which determines the persons
to whom awards will be granted, the number of awards to be granted and the specific terms of each grant, including the vesting
thereof, subject to the provisions of the plan.



In
connection with Incentive Stock Options, the exercise price of each option may not be less than 100% of the fair market value
of the common stock on the date of the grant (or 110% of the fair market value in the case of a grantee holding more than 10%
of the outstanding stock of the Company). The aggregate fair market value (determined at the time of the grant) of stock for which
an employee may exercise Incentive Stock Options under all plans of the company shall not exceed $1,000,000 per calendar year.
If any employee shall have the right to exercise any options in excess of $100,000 during any calendar year, the options in excess
of $100,000 shall be deemed to be Non-Statutory Stock Options, including prices, duration, transferability and limitations on
exercise.



The
Company issued non-statutory stock options pursuant to contractual agreements to non-employees. Options granted under the agreements
are expensed when the related service or product is provided.













LaserLock
Technologies, Inc. and Subsidiary

(A
Development Stage Company)

Notes
to Condensed Consolidated Financial Statements (Unaudited)



NOTE
7 – STOCK OPTIONS AND WARRANTS (Continued)



The
following tables summarize non-employee stock option/warrant activity of the Company since December 31, 2011:











| |                                     |                |  |          |            | Weighted Average
| | ----------------------------------- | -------------- |  | -------- | ---------- | ----------------
| |                                     | Option/Warrant |  | Exercise |            | Exercise        
| |                                     | Shares         |  | Price    |            | Price           
| |                                     |                |  |          |            |                 
| | Outstanding, December 31, 2011      |                |  |          | 15,385,996 |                 
| |                                     |                |  |          |            |                 
| | Granted                             |                |  |          | —          |                 
| | Exercised                           |                |  |          | —          |                 
| | Expired                             |                |  |          | —          |                 
| |                                     |                |  |          |            |                 
| | Outstanding, March 31, 2012         |                |  |          | 15,385,996 |                 
| |                                     |                |  |          |            |                 
| | Exercisable, March 31, 2012         |                |  |          | 15,385,996 |                 
| |                                     |                |  |          |            |                 
| | Weighted Average Remaining Life,    |                |  |          |            |                 
| | Exercisable, March 31, 2012 (years) |                |  |          | 6.1        |                 







A summary of incentive stock option transactions
for employees since December 31, 2011 is as follows:







| |                                  |        |  |          |           | Weighted Average
| | -------------------------------- | ------ |  | -------- | --------- | ----------------
| |                                  | Option |  | Exercise |           | Exercise        
| |                                  | Shares |  | Price    |           | Price           
| |                                  |        |  |          |           |                 
| | Outstanding, December 31, 2011   |        |  |          | 6,390,000 |                 
| |                                  |        |  |          |           |                 
| | Granted                          |        |  |          | —         |                 
| | Exercised                        |        |  |          | —         |                 
| | Expired/Returned                 |        |  |          | —         |                 
| |                                  |        |  |          |           |                 
| | Outstanding, March 31, 2012      |        |  |          | 6,390,000 |                 
| |                                  |        |  |          |           |                 
| | Exercisable, March 31, 2012      |        |  |          | 6,390,000 |                 
| |                                  |        |  |          |           |                 
| | Weighted Average Remaining Life, |        |  |          |           |                 
| | Exercisable, March 31, 2012      |        |  |          | 9.1       |                 























LaserLock
Technologies, Inc. and Subsidiary

(A
Development Stage Company)

Notes
to Condensed Consolidated Financial Statements (Unaudited)



NOTE
8 – RELATED PARTY TRANSACTIONS



At
March 31, 2012 and December 31, 2011, five shareholders of the Company held $577,500 of the senior secured convertible notes payable.



One
shareholder held $140,000 of convertible notes payable as of March 31, 2012 and December 31, 2011.



At
March 31, 2012 and December 31, 2011, two shareholders of the Company held $636,500 of unsecured notes payable.



The
Company maintains its office at the home of its Chief Executive Officer and President. No formal lease agreement exists and no
direct rent expense has been incurred. However, related occupancy costs of $8,359 and $2,986, respectively, were incurred during
the three months ended March 31, 2012 and 2011.





NOTE
9 – MAJOR CUSTOMERS AND VENDORS



During
the three months ended March 31, 2012, the Company earned a substantial portion of its revenue from one customer in the amount
of $12,000. At March 31, 2012, the amount due from this customer, included in trade accounts receivable, was $2,000. During the
three months ended March 31, 2011, the Company earned a substantial portion of its revenue from two customers totaling $1,890
and $900, respectively.



NOTE
10 – SUBSEQUENT EVENTS



Litigation
Matters

In
October 2010, the Company filed suit in the Western District of Pennsylvania against WS Packaging Group, Inc. (“WS”)
alleging that WS infringed on one of the Company’s patents in the manufacture of MONOPOLY game pieces on behalf of McDonald’s
Corp. On June 4, 2012, both WS and the Company filed a stipulation to dismiss the action without prejudice and enter into settlement
negotiations. Settlement negotiations are ongoing.



Notes
Payable Issuance

In
April 2012, the Company raised $200,000 from a shareholder through the issuance of unsecured notes payable. The note accrues interest
at 10% per annum. All principal and accrued interest are due to mature in one year from the date of issuance.



Options

In
July 2012, the Company issued an option to purchase 200,000 shares of the Company’s common stock at an exercise price of
$0.05, with a term of ten years, to a consultant in exchange for future services.

Employment
Agreement

The
Chief Executive Officer’s employment agreement was extended to November 2017, with an increase in salary from $180,000 to
$220,000 effective July 2012. In addition, the Company will continue to pay all ongoing expenses for the property location of
the corporate headquarters, which is owned by the Chief Executive Officer.





ITEM
2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND

RESULTS
OF OPERATIONS.





Cautionary
Statements Regarding Forward-Looking Statements



This
report contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended
(the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act").
All statements other than statements of historical facts included or incorporated by reference in this quarterly report on Form
10-Q, including without limitation, statements regarding our future financial position, business strategy, budgets, projected
revenues, projected costs and plans and objective of management for future operations, are forward-looking statements. In addition,
forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "will,"
"expects," "intends," "plans," "projects," "estimates," "anticipates,"
or "believes" or the negative thereof or any variation thereon or similar terminology or expressions.



We
have based these forward-looking statements on our current expectations and projections about future events. These forward-looking
statements are not guarantees and are subject to known and unknown risks, uncertainties and assumptions about us that may cause
our actual results, levels of activity, performance or achievements to be materially different from any future results, levels
of activity, performance or achievements expressed or implied by such forward-looking statements. Important factors that could
cause actual results to differ materially from our expectations include, but are not limited to:  our ability to raise
additional capital, the absence of any operating history or revenue, our ability to attract and retain qualified personnel, our
dependence on third party developers who we cannot control, our ability to develop and introduce a new service to the market in
a timely manner, market acceptance of our services, our limited experience in a relatively new industry, the ability to successfully
develop licensing programs and generate business, rapid technological change in relevant markets, unexpected network interruptions
or security breaches, changes in demand for current and future intellectual property rights, legislative, regulatory and competitive
developments, intense competition with larger companies, general economic conditions, as well as other factors set forth under
the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2011 filed with the Securities
and Exchange Commission, and “Item 2 — Management’s Discussions and Analysis of Financial Condition and
Results of Operation” below.



All
subsequent written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified
in their entirety by the foregoing. Except as required by law, we assume no duty to update or revise our forward-looking statements.



Overview



We
were incorporated in Nevada in November 1999. We are a technology development company that delivers product and document authentication
and security. We plan to develop and market technologies in a variety of applications in the security fields.



We
believe that the technologies we own will enable businesses to reconstruct their overall approaches to corporate security - from
counterfeit identification to employee or customer monitoring. Potential applications of our technologies are available in different
types of products and industries - e.g., gaming, apparel, tobacco, perfume, compact disks, pharmaceuticals, event and transportation
tickets, driver's licenses, insurance cards, passports, computer software, DVDs, and credit cards. We intend to generate sales
through licenses of our technology or through direct sales of our technology to end-users.



We
have filed a total of five patent applications relating to our technology, which have all been issued. These patents seek to accomplish
non-intrusive document and product authentication in order to reduce losses caused by unpermitted document reproduction or by
product counterfeiting. The technologies involve the utilization of invisible or color shifting/changing inks, which are compatible
with today's printing machines. The inks may be used with certain printing systems such as offset, flexographic, silkscreen, gravure,
and laser. Based upon the Company’s experience, we believe that the ink technologies may be incorporated into existing manufacturing
processes. We believe that some of our patents may have non-security applications and we are attempting to commercialize these
opportunities.









Strategic
Outlook



We
believe that the security and authentication industries will continue to grow over time, especially as counterfeiting becomes
easier with advances in technology. Within the market, we intend to provide our products to government bodies, and merchants in
the consumer products, gaming and financial services industries.



Sustained
spending on technology, our ability to raise additional financing, and the continued growth of the security and authentication
markets are all external conditions that may affect our ability to execute our business plan. In addition, certain potential customers
may view our small size and limited financial resources as a negative even if they prefer our products to those of our competitors.



Our
primary strategic objective over the next 12-24 months is to raise additional financing in order to successfully market our products
and generate revenue that is sufficient to cover our operating expenses and support additional growth over the next several years.



We
believe that our near-term success will depend particularly on our ability to develop customer awareness and confidence in our
products. Since we have limited capital resources, we will need to closely manage our expenses and conserve our cash by continually
monitoring any increase in expenses and reducing or eliminating unnecessary expenditures. Our prospects must be considered in
light of the risks, expenses and difficulties encountered by companies in the development stage, particularly given that we operate
in rapidly evolving markets, that we have limited financial resources, and face an uncertain economic environment. We may not
be successful in addressing such risks and difficulties.



Results
of Operations



Comparison
of the Three Months Ended March 31, 2012 and 2011



The
following discussion analyzes our results of operations for the three months ended March 31, 2012 and 2011. The following information
should be considered together with our financial statements for such period and the accompanying notes thereto.



Net
Loss for Three Months Ended March 31, 2012 and 2011



Revenue/Net
Loss



We
are a development stage company and have not generated significant revenue since our inception.  For the three months
ended March 31, 2012 and 2011, we generated revenues of $13,740 and $2,790, respectively.  Our net loss increased $52,372
to $235,605 for the three months ended March 31, 2012 compared to $183,233 for the three months ended March 31, 2011, as a result
of increased expenses as further described below.



Cost
of Sales



For
the three months ended March 31, 2012 and 2011, we incurred costs of sales of $2,036 and $373, respectively. The increase in cost
of sales was consistent with the increase in revenue in 2012 compared to 2011.



Research
and Development



Research
and development expenses were $1,257 and $0 for the three months ended March 31, 2012 and 2011, respectively. The increase in
research and development expenses was due to the timing of research and development activities.







Legal
and Accounting



Legal
and accounting fees increased $80,378 to $90,347 for the three months ended March 31, 2012 from $9,969 for the three months ended
March 31, 2011.  The professional fees were for legal, accounting and other professional services. The increase in legal
and accounting fees is primarily related to a patent infringement lawsuit as well as for preparation of filings to bring the Company
back into compliance with the filing requirement under the Exchange Act.



Sales
and Marketing



Sales
and marketing expenses for the three months ended March 31, 2012 were $48,308 as compared to $51,778 for the three months ended
March 31, 2011, a decrease of $3,470.   The expenses consisted largely of expenses associated with marketing the new
technology associated with the SecureLight patent issued in 2011.



General
and Administrative



For
the three months ended March 31, 2012 general and administrative expenses were $35,690, a decrease of $4,091 from $39,781 for
the three months ended March 31, 2011.  The decrease resulted primarily from a decrease in insurance of $8,000 offset
by an increase in occupancy costs of $5,000.



Interest
Expense



During
the three months ended March 31, 2012, we incurred interest expense of $71,707, as compared to $84,173 for the three months ended
March 31, 2011. The decrease in interest expense directly correlates to the decrease in the interest rate negotiated for the extension
of certain notes payable in June 2011.









Liquidity
and Capital Resources



As
of the date of this report, we had cash on hand of $96,150.



Net
cash used in operating activities for the three months ended March 31, 2012 was $33,780 compared to $55,427 for the three months
ended March 31, 2011, a decrease of $21,647. The decrease in net cash used in operating activities is mainly related to an increase
in accounts payable and accrued expenses.



Net
cash used in investing activities was $0 for the three months ended March 31, 2012 and 2011.



Net
cash provided by financing activities was $0 for the three months ended March 31, 2012 and 2011.



In
February 2006, the Company commenced a private placement of up to $800,000 principal amount of senior secured convertible promissory
notes. As of March 31, 2012, $781,500 of these notes were outstanding. In June 2011, the due dates on these notes were extended
as follows: $90,000 in September 2013; $95,000 in September 2014; $596,500 in September 2015. The interest rate associated with
$762,500 of the notes is 10% per annum, while the remaining $19,000 of the notes is at 12% per annum. In addition, if an equity
financing with total proceeds of more than $5,000,000 occurs while any notes are outstanding, holders of notes will have the right,
at their option, to convert the outstanding principal and interest of the notes into shares at a discount of 30% of the price
per share in the qualified financing. Accrued interest on these notes at March 31, 2012 amounted to $541,298.



During
2007, the Company commenced a private placement of up to $400,000 principal amount of10% Convertible Promissory Notes.
As of March 31, 2012, the outstanding principal balance on the notes was $140,000.  Holders of Notes will have the right,
at their option, to convert the outstanding principal and interest of the Notes into shares of the Company’s Series A Preferred
Stock at any time and from time to time at the option of the holder at the initial conversion price of $0.005333 per share. The
Notes are unsecured.





In
June 2011, the noteholder of the $140,000 under this convertible note issue agreed to extend the maturity date of these notes
to September 30, 2015 at an interest rate of 10% per annum. Additionally, the noteholder agreed in writing to suspend its right
to convert its notes until such time as the Company’s authorized shares have been increased. Remaining shares to be potentially
issued under this convertible note issue are 26,250,000.  Accrued interest on these notes at March 31, 2012 amounted to $68,250.



As
of March 31, 2012, the Company has outstanding unsecured notes payable of $561,000, which bear interest at the rate of 10% per
annum. During June 2011, the due date of these notes was extended to September 30, 2015. As of March 31, 2012, accrued interest
on these notes payable amounted to $214,643.



In
August 2009, the Company commenced a private placement of up to $300,000 consisting of up to 6 units. Each unit consists of a
$50,000, 8% Series A Note Payable, due September 30, 2011, and a warrant to purchase 2,000,000 shares of the Company’s common
stock. The notes are unsecured. The Company sold 4.5 units under this private placement. As of March 31, 2012, $200,000 of these
8% Series A Notes Payable remain outstanding. In June 2011, $150,000 of the 8% Series A Notes Payable and the associated 6,000,000
warrants were extended to September 30, 2015. The remaining $50,000 was due in October 2011 and is currently past due. Accrued
interest on the 8% Series A Notes Payable at March 31, 2012 amounted to $40,667.









In
2010, the Company issued $400,000 in notes payable in order to finance a patent infringement lawsuit (see Subsequent Events Note
10). The notes payable accrue interest at 25% per annum and mature upon the earlier of September 1, 2013 or the date on which
the Company receives net proceeds from the patent infringement claim. In addition to the base interest of 25% per annum, interest,
accruing to maturity the lenders are entitled to Bonus Interest equal to the following:



| | a. | First
    monies realized by the Company from its share of the net proceeds of the lawsuit shall be allocated and paid to the Lender
    until the principal and base interest accruing has been fully paid.
| | -- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | b. | The
    next monies from the net proceeds of the litigation settlement will be paid to the Company to reimburse for out-of-pocket
    legal costs related to the lawsuit.
| | -- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | c. | The
    next $825,000 of proceeds will be split 50%/50% between the Company and the Lenders.
| | -- | --------------------------------------------------------------------------------------------



| | d. | The
    next $1 million realized by the Company shall be allocated 90% to the Company and 10% to the Lenders.
| | -- | -------------------------------------------------------------------------------------------------------------



| | e. | The
    next $1 million realized by Company shall be allocated 85% to Company and 15% to Lenders.
| | -- | -------------------------------------------------------------------------------------------------



| | f. | All
    remaining proceeds realized by Company shall be allocated 80% to Company and 20% to Lenders.
| | -- | ----------------------------------------------------------------------------------------------------



Accrued
interest on these 25% notes payable at March 31, 2012 amounted to $150,521.



The
Company is in the development stage. During the three months ended March 31, 2012, the Company’s operational resources were
used primarily to fund general and administrative expenses to continue operations and a significantly reduced sales and marketing
program.



As
we have not realized significant revenues since our inception, we have financed our operations through public and private offerings
of debt and equity securities.  We do not currently maintain a line of credit or term loan with any commercial bank
or other financial institution.



Since
our inception, we have focused on developing and implementing our business plan.   Our business plans are dependent
on our ability to raise capital through private placements of our common stock and/or preferred stock, through the possible
exercise of outstanding options and warrants, through debt financing and/or through a future public offering of our securities.
There is no assurance that we will raise sufficient capital in order to meet our goals of implementing a sales and marketing
effort to introduce the products.  We believe that our existing cash resources will not be sufficient to sustain our
operations during the next twelve months. We intend to raise such financing through private placements and/or the
sale of debt and equity securities.  The issuance of additional equity would result in dilution to our existing shareholders.  If
we are unable to obtain additional funds when they are needed or if such funds cannot be obtained on terms favorable to us, we
may be unable to execute upon our business plan or pay our costs and expenses as they are incurred, which could have a material,
adverse effect on our business, financial condition and results of operations.



Even
if we are successful in raising sufficient capital in order to complete the marketing program for our products, our ability
to continue in business as a viable going concern can only be achieved when our revenues reach a level that sustains our
business operations. While it is impossible to predict the amount of revenues, if any, that we may receive from our products,
we presently believe, based solely on our internal projections, that we will generate revenues sufficient to fund our planned
business operations if the products are marketed effectively in accordance with our plans.  There can be no assurance
that we will raise sufficient proceeds, or any proceeds, for us to implement fully our proposed business plan.  Moreover
there can be no assurance that even if our products are marketed effectively, that we will generate revenues sufficient to fund
our operations.  In either situation, we may not be able to continue our operations and our business might fail.





Off-Balance
Sheet Arrangements



As
of March 31, 2012, we did not have any relationships with unconsolidated entities or financial partners, such as entities often
referred to as structured finance or special purpose entities, established for the purpose of facilitating off-balance sheet arrangements
or other contractually narrow or limited purposes.  As such, we are not materially exposed to any financing, liquidity,
market or credit risk that could arise if we had engaged in such relationships.



Critical
Accounting Policies



Our
financial statements are impacted by the accounting policies used and the estimates and assumptions made by management during
their preparation. We have identified below the accounting policies that are of particular importance in the presentation of our
financial position, results of operations and cash flows and which require the application of significant judgment by management.









Stock-based
Compensation



We
account for stock-based compensation under the provisions of FASB ASC Topic 718,  Compensation—Stock Compensation   (“ASC
718”), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees
and directors based on estimated fair values on the grant date. We estimate the fair value of stock-based awards on the date of
grant using the Black-Scholes model.  The value of the portion of the award that is ultimately expected to vest is recognized
as expense over the requisite service periods using the straight-line method.



We
account for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 505-50, Equity-Based Payments to
Non-Employees   (“ASC 505-50”). Under ASC 505-50, we determine the fair value of the warrants or stock-based
compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments
issued, whichever is more reliably measurable.



All
issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the
Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees
are recorded as an expense and additional paid-in capital in stockholders’ equity over the applicable service periods using
variable accounting through the vesting dates based on the fair value of the options at the end of each period.



Revenue
Recognition



In
accordance with Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin No. 104, Revenue Recognition
(Codified in FASB ASC 605), we recognize revenue when (i) persuasive evidence of a customer or distributor arrangement exists,
(ii) a retailer, distributor or wholesaler receives the goods and acceptance occurs, (iii) the price is fixed or determinable,
and (iv) collectibility of the sales revenues is reasonably assured. Subject to these criteria, the Company recognizes revenue
from product sales, consisting mainly of pigments and penlights, upon shipment to the customer.  Royalty revenue is recognized
upon receipt of notification from a customer that the Company’s product has been used in the customer’s production
process.





Recently
Issued Accounting Pronouncements



Recently
issued accounting pronouncements are discussed in Note 1 of the Notes to the Condensed Consolidated Financial Statements.





ITEM
3. Quantitative and qualitative Disclosures about market risk



Not
Applicable



ITEM
4.	CONTROLS AND PROCEDURES.



As
of March 31, 2012, we carried out the evaluation of the effectiveness of our disclosure controls and procedures required by Rule
13a-15(e) under the Exchange Act under the supervision and with the participation of our management, including our Chief Executive
Officer and Principal Financial Officer. Based upon that evaluation, our Chief Executive Officer and Principal Financial Officer
concluded that, as of March 31, 2012, our disclosure controls and procedures were not effective
to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is: (i) recorded,
processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and (ii) accumulated
and communicated to our management, including our Chief Executive Officer and Principal Financial Officer, as appropriate to allow
timely decisions regarding required disclosure, because of the material weakness described below.



A
material weakness is a control deficiency, or combination of control deficiencies, that results in more than a remote likelihood
that a material misstatement of the financial statements would not be prevented or detected. A material weakness in the Company’s
internal controls exists in that there is limited segregation of duties amongst the Company’s employees with respect to
the Company’s preparation and review of the Company’s financial statements. This material weakness is a result of
the Company’s limited number of personnel. This material weakness may affect management’s ability to effectively review
and analyze elements of the financial statement closing process and prepare financial statements in accordance with U.S. GAAP.



There
has been no change in our internal control over financial reporting identified in connection with this evaluation that occurred
during our fiscal quarter ended March 31, 2012 that has materially affected, or is reasonably likely to materially affect, our
internal control over financial reporting.







PART
II – OTHER INFORMATION



ITEM
6.	EXHIBITS.



|31.1    | Certification
    of Chief Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange
    Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|        |                                                                                                                                                                                                                                                   
|32.1    | Certification
        of Chief Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
        Section 906 of the Sarbanes-Oxley Act of 2002.                                                
|        |                                                                                                                                                                                                                                                   
|101.INS | XBRL
    Instance Document                                                                                                                                                                                                                        
|        |                                                                                                                                                                                                                                                   
|101.SCH | XBRL
    Taxonomy Extension Schema Document                                                                                                                                                                                                       
|        |                                                                                                                                                                                                                                                   
|101.CAL | XBRL
    Taxonomy Extension Calculation Linkbase Document                                                                                                                                                                                         
|        |                                                                                                                                                                                                                                                   
|101.DEF | XBRL
    Taxonomy Extension Definition Linkbase Document                                                                                                                                                                                          
|        |                                                                                                                                                                                                                                                   
|101.LAB | XBRL
    Taxonomy Extension Label Linkbase Document                                                                                                                                                                                               
|        |                                                                                                                                                                                                                                                   
|101.PRE | XBRL
    Taxonomy Extension Presentation Linkbase Document                                                                                                                                                                                        













SIGNATURE



Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.



LASERLOCK
TECHNOLOGIES, INC.







Date:	August
24, 2012	By:	/s/ Norman A. Gardner

Norman
A. Gardner

Chairman
of the Board,

Chief
Executive Officer,

and
President







Exhibit
31.1



CERTIFICATION
OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFCER

PURSUANT
TO RULES 13a-14a AND 15d-14a

OF
THE SECURITIES AND EXCHANGE ACT OF 1934

AS
ADOPTED PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY
ACT OF 2002



I,
Norman A. Gardner, certify that:



1.	I
have reviewed this quarterly report on Form 10-Q of LaserLock Technologies, Inc.;



2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
to the period covered by this report;



3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;



4.
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the
registrant and have:



|(a) |  | Designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;
|--- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| |  | 
| |  | 

|(b) |  | Designed such internal control
over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;
|--- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| |  | 
| |  | 

|(c) |  | Evaluated the effectiveness
of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|--- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| |  | 
| |  | 

|(d) |  | Disclosed in this report any
change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or
is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|--- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| |  | 
| |  | 

5.
I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s
auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

| |  | 
| |  | 

|(a) |  | All significant deficiencies
and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to
adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|--- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| |  | 
| |  | 

|(b) |  | Any fraud, whether or not material,
that involves management or other employees who have a significant role in the registrant’s internal control over financial
reporting.
|--- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| |  | 
| |  | 





Date:
August 24, 2012	By:	/s/ Norman A. Gardner

Norman
A. Gardner

Chief
Executive Officer and Principal

Financial
Officer











Exhibit
32.1



CERTIFICATION
OF

CHIEF
EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

OF
LASERLOCK TECHNOLOGIES, INC.

PURSUANT
TO 18 U.S.C. SECTION 1350





In
connection with the Quarterly Report on Form 10-Q of LaserLock Technologies, Inc. (the "Company") for the period ended
March 31, 2012, as filed with the Securities and Exchange Commission (the "Report"), I, Norman A. Gardner, Chief Executive
Officer and Principal Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, that to my knowledge:



| | (1) | The
                                                                                                                               Report
                                                                                                                               fully
                                                                                                                               complies
                                                                                                                               with
                                                                                                                               the
                                                                                                                               requirements
                                                                                                                               of
                                                                                                                               Section
                                                                                                                               13(a)
                                                                                                                               or
                                                                                                                               15(d)
                                                                                                                               of
                                                                                                                               the
                                                                                                                               Securities
                                                                                                                               Exchange
                                                                                                                               Act
                                                                                                                               of
                                                                                                                               1934;
                                                                                                                               and
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (2) | The
                                                                                                                               information
                                                                                                                               contained
                                                                                                                               in
                                                                                                                               the
                                                                                                                               Report
                                                                                                                               fairly
                                                                                                                               presents,
                                                                                                                               in
                                                                                                                               all
                                                                                                                               material
                                                                                                                               respects,
                                                                                                                               the
                                                                                                                               financial
                                                                                                                               condition
                                                                                                                               and
                                                                                                                               results
                                                                                                                               of
                                                                                                                               operations
                                                                                                                               of
                                                                                                                               the
                                                                                                                               Company.
| | --- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------







Date:
August 24, 2012	/s/ Norman A. Gardner

Norman
A. Gardner

Chief
Executive Officer and Principal Financial Officer